Gliptagreat M Tablet is an anti-diabetic oral medication that combines Vildagliptin (a DPP-4 inhibitor) with Metformin (a biguanide) to support balanced blood sugar levels in adults managing type 2 diabetes. This fixed-dose combination is commonly considered when lifestyle changes and monotherapy have not provided adequate control and is usually part of a larger care plan overseen by a healthcare provider. By targeting two different aspects of glucose regulation it supports a smoother glycemic profile throughout the day.